Sign inGet started

Groen Eric

Insider CIK 1918630 · GNLX General Counsel & Secretary · RANI General Counsel

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
GNLX GENELUX Corp A Award2026-06-162026-06-18233,957— $0233,957SEC↗
GNLX GENELUX Corp A Award deriv2025-07-012025-07-02270,000— $0270,000SEC↗
RANI Rani Therapeutics Holdings A Award deriv2024-03-212024-03-22323,500— $0323,500SEC↗
RANI Rani Therapeutics Holdings A Award deriv2023-12-162023-12-19171,500— $0171,500SEC↗
RANI Rani Therapeutics Holdings D To issuer deriv2023-12-162023-12-19171,500— $034,300SEC↗
RANI Rani Therapeutics Holdings D To issuer deriv2023-12-162023-12-1954,167— $075,833SEC↗
RANI Rani Therapeutics Holdings A Award deriv2023-12-162023-12-1943,400— $043,400SEC↗
RANI Rani Therapeutics Holdings A Award deriv2023-12-162023-12-1954,167— $054,167SEC↗
RANI Rani Therapeutics Holdings D To issuer deriv2023-12-162023-12-1943,400— $031,000SEC↗
RANI Rani Therapeutics Holdings A Award deriv2023-03-272023-03-29205,800— $0205,800SEC↗
RANI Rani Therapeutics Holdings A Award2023-03-272023-03-29139,000— $0163,216SEC↗
RANI Rani Therapeutics Holdings F Tax w/h2023-03-222023-03-242,498$5.95 $14.9K24,216SEC↗
RANI Rani Therapeutics Holdings A Award deriv2022-03-222022-03-2474,400— $074,400SEC↗
RANI Rani Therapeutics Holdings A Award2022-03-222022-03-2424,500— $024,500SEC↗